IDiyas

For the Inventor, By the Inventor

Hyderabad Telangana, India

Suven Life Sciences Limited


USPTO Granted Patents = 53



Forward Citations = 54

Loading Chart...
Loading Chart...

111 inventors (with patents filed for the assignee):

goldMedal Venkateswarlu Jasti (51 out of 57 patents)

silverMedal Ramakrishna Nirogi (35 out of 38 patents)

bronzeMedal Anil Karbhari Shinde (34 out of 36 patents)

4.  Abdul Rasheed Mohammed (19 out of 20 patents)

5.  Pradeep Jayarajan (18 out of 19 patents)

6.  Rama Sastri Kambhampati (16 out of 17 patents)

7.  Gopinadh Bhyrapuneni (12 out of 13 patents)

8.  Venkata Satya Nirogi Ramakrishna (9 out of 10 patents)

9.  Ramasastri Kambhampati (8 out of 9 patents)

10.  Ishtiyaque Ahmad (7 out of 12 patents)

11.  Vijay Sidram Benade (6 out of 6 patents)

12.  Nagaraj Vishwottam Kandikere (6 out of 6 patents)

13.  Venkata Satya Veerabhadra Vadlamudi Rao (6 out of 7 patents)

14.  Rajesh Kumar Badange (5 out of 5 patents)

15.  Ramkumar Subramanian (5 out of 5 patents)


Core Competencies:
Pharmaceutical Compositions
CNS Disorders
5-HT4 Receptor Agonists
Muscarinic M1 Receptor Modulators
Histamine H3 Receptor Ligands
5-HT6 Receptor Antagonists
Piperidine Compounds
Acrylamide Compounds
Serotonin Receptor Affinity
Indole Derivatives
Polycyclic Amides
Tetracyclic Indoles

53 patents:

1. 12397003 - Amorphous pharmaceutical compositions of abiraterone acetate (2025-08-26),
2. 12391698 - Substituted piperidines and piperazines and methods for the treatment of CNS disorders (2025-08-19),
3. 12338236 - Benzoisothiazole and benzoisoxazole compounds for the treatment of mental disorders (2025-06-24),
4. 12285421 - Uses of a 5-HT4 receptor agonist (2025-04-29),
5. 12275746 - Pyrrolo[1,2-b]-2-pyridazinone compounds as 5-HT4 receptor agonists (2025-04-14),
6. 12156871 - Substituted azacycles as muscarinic M1 receptor positive allosteric modulators (2024-12-03),
7. 12122779 - Pyrrolo-pyridazine derivatives as muscarinic M1 receptor positive allosteric modulators (2024-10-22),
8. 11622967 - Method of treatment with histamine-3 receptor inverse agonist (2023-04-11),
9. 11458135 - Combination of pure 5-HT6 receptor antagonists with acetylcholinesterase inhibitors (2022-10-04),
10. 11278530 - Polycyclic amides as muscarinic M1 receptor positive allosteric modulators (2022-03-22),
11. 11253514 - Triple combination of pure 5-HTreceptor antagonists, acetylcholinesterase inhibitors and NMDA receptor antagonist (2022-02-22),
12. 11234979 - Heteroaryl compounds as muscarinic M1 receptor positive allosteric modulators (2022-02-01),
13. 11116764 - Combination of pure 5-HT6 receptor antagonists with NMDA receptor antagonist (2021-09-14),
14. 11040026 - Muscarinic M1 receptor positive allosteric modulators (2021-06-22),
15. 10973831 - Fluoropiperidine compounds as pure 5-HT 6 receptor antagonists (2021-04-13),
Suven Life Sciences Limited is a research-focused pharmaceutical company specializing in discovering, developing, and commercializing innovative therapeutics. With a diverse portfolio, Suven focuses on drug discovery and development for central nervous system disorders. They have a strong presence in the global market and are committed to improving the lives of patients through their novel pharmaceutical products.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

53 Patents

#3 in Hyderabad Telangana

#34 in India

#12,924 in the World

...
Hyderabad Telangana, India

Suven Life Sciences Limited

Forward Citations = 54

111 inventors:

goldMedal Venkateswarlu Jasti (51 out of 57 patents)

silverMedal Ramakrishna Nirogi (35 out of 38 patents)

bronzeMedal Anil Karbhari Shinde (34 out of 36 patents)

4.  Abdul Rasheed Mohammed (19 out of 20 patents)

5.  Pradeep Jayarajan (18 out of 19 patents)

Please report any incorrect information to support@idiyas.com
Loading…